The bargain is anticipated to enclose the 3rd quarter.
发布者：Dr.Durant，转转请注明出处：https://robotalks.cn/eli-lilly-acquires-biotech-company-for-usd-1-3bn/
关于作者
Roche to test Parkinson’s drug in phase 3 trial despite previous study failures
上一篇
18 6 月, 2025 1:18 上午
Pfizer to reconsider its position in the EU after new proposal: “It does not raise interest”
下一篇
18 6 月, 2025 1:18 上午
相关推荐
-
Intelligent swarm: Working in a team is also relevant for drones
Uncrewed airborne lorries (UAVs), generally called drones, are universal and have actually expanded in appeal because of their large prospective usage in several private fields. Ou…
-
Air Data Systems
Tabulation: What Are Air Data Systems? Key Components of an Air Data System The Role of AHRS in Air Data Systems How Air Data Systems Enhance Operations Data Provided by Air Data S…
-
FDA rejects Applied Therapeutics’ drug to treat galactosemia
Applied Rehabs intends to ask for a conference with the United States wellness authorities to talk about demands for a possible resubmission or an allure of the choice.
-
Researcher designs robot to help children cross streets safely
It looks a little bit like a tiny lawnmower, yet as opposed to twin manages, a solitary black post with a tablet-sized display affixed surges from the device.
-
Ouster Announces Transfer of Stock Exchange Listing to Nasdaq
SAN FRANCISCO–(BUSINESS WIRE)–Ouster, Inc. (NYSE: OUST) today announced that it will transfer the listing of its common stock and its warrants to purchase common stock …
